ROCHE_WEB THUMBNAIL

April 16, 2024

Faricimab – The Fight Against Retinal Diseases

Faricimab (Vabysmo) is the first approved bispecific antibody uniquely engineered to block two key pathways driving retinal vascular disease by…

popular posts

Article 2 Day 5_ ARVO

May 9, 2025

The Next-Gen Arsenal of Genomic Tools for IRDs and Other Eye Diseases Lighting Up ARVO 2025

Article 2 Day 4_ARVO

May 8, 2025

Beyond the Genetic Code at ARVO 2025: Breakthrough Approaches to Retinal Repair

latest posts

Article 2 Day 5_ ARVO

May 9, 2025

The Next-Gen Arsenal of Genomic Tools for IRDs and Other Eye Diseases Lighting Up ARVO 2025

Article 2 Day 4_ARVO

May 8, 2025

Beyond the Genetic Code at ARVO 2025: Breakthrough Approaches to Retinal Repair

ROCHE_WEB THUMBNAIL

April 16, 2024

Faricimab – The Fight Against Retinal Diseases

Montage_photo_Filloy_def_17072023

December 4, 2023

SubLiminal Laser Therapy for CSCR: A New Front-line Treatment

shutterstock_1616300053

December 7, 2023

Could Eye Drops Replace Injections? Experts provide insights into the prospects and challenges of using eye drops to treat retinal conditions

Discover our fascinating content at issuu

explore